Ganoderma lucidum and its pharmaceutically active compounds

Biotechnology Annual Review

Volumn 13, Issue , 2007, Pages 265-301

  Boh, Bojana ^a   Berovic, Marin ^a   Zhang, Jingsong ^b   Zhi Bin, Lin ^c  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF EDIBLE FUNGI   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

d glucans; anti cancer effects; cultivation; Ganoderma lucidum; immunomodulation.; pharmacological effects; polysaccharides; sawdust; solid state cultivation; submerged cultivation; triterpenoids; wood logs

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; BETA GLUCAN; CHOLESTEROL; COMPLEMENT; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; FREE RADICAL; GAMMA INTERFERON; GANODERMA LUCIDUM EXTRACT; HISTAMINE; MUTAGENIC AGENT; POLYSACCHARIDE; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANGIOGENESIS; ANOREXIA; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BASIDIOMYCETES; BIOREACTOR; BIOTECHNOLOGY; BLADDER NECK STENOSIS; CANCER INHIBITION; CANCER MORTALITY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DAMAGE; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; COMPLEMENT INHIBITION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE MODEL; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG MARKETING; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME INHIBITION; FUNGAL BIOMASS; GANODERMA LUCIDUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOMODULATION; INHIBITION KINETICS; LEUKOPENIA; LIQUID CULTURE; LIVER DYSFUNCTION; LIVER METASTASIS; LIVER PROTECTION; LUNG CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; METASTASIS INHIBITION; MONOTHERAPY; MUSHROOM; MYCELIUM; NATURAL KILLER CELL; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLASTIC BOTTLE; REVIEW; SAWDUST; SUBMERGED CELL CULTURE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; TUMOR VASCULARIZATION; UPREGULATION; WOOD;

DRUGS, CHINESE HERBAL; POLYSACCHARIDES; REISHI; TRITERPENES;

BASIDIOMYCOTA; GANODERMA LUCIDUM;

EID: 34548598182     PISSN: 13872656     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1387-2656(07)13010-6     Document Type: Review

References (153)

1. Leung SWS. Lingzhi (Ganoderma) research - the past, present and future perspectives. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, Beijing, Medical University Press, 2002, pp. 1-9.
2. Kim HW and Kim BK. Recent advances on the biologically active triterpenoids of Ganoderma lucidum. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, Beijing, Medical University Press, 2002, pp. 10-19.
3. Jong S.C., and Birmingham J.M. Medicinal benefits of the mushrooms Ganoderma. Adv Appl Microbiol 37 (1992) 101-134
4. Tasaka K., Akagi M., Miyoshi K., Mio M., and Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum. 1. Inhibitory effect of oleic acid on histamine release. Agents Action 23 (1988) 153-156
5. Kino K., Sone T., Watanabe J., Yamashita A., Tsuboi H., Miyajima H., and Tsunoo H. Immunomodulator, LZ-8, prevents antibody-production in mice. Int J Immunopharmacol 13 (1991) 1109-1115
6. van Der Hem L.G., Van Der Vliet J A., Bocken C F M., Kino K., Hoitsma A J., and Tax W.J.M. Ling zhi-8 - studies of a new immunomodulating agent. Transplantation (Baltimore) 60 (1995) 438-443
7. Maruyama H., Yamazaki K., Murofushi S., Konda C., and Ikekawa T. Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Pharmacobio-Dyn 12 (1989) 118-123
8. Lee S.Y., and Rhee H M. Cardiovascular effects of mycelium extract of Ganoderma lucidum - inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull 38 (1990) 1359-1364
9. Liu G.T., Bao X., Niu S., Li Z., and Sung Z. Some pharmacological actions of the spores of Ganoderma lucidum and the mycelium of Ganoderma capense (Lloyd) Teng cultivated by submerged fermentation. Chin Med J 92 (1979) 469-500
10. Hirose K, Muto S, Niimura K, Ohara M, Oguchi Y, Matsunaga K, Kadochi J, Sugita N, Furushu T, Yoshikumi C and Takahashi M. Antiviral agent. Japanese Patent JP 63316734, 1988.
11. Mizumoto K, Yamashita A, Kii M and Sumio H. Antiretrovirus agent. Japanese Patent JP 2032026, 1990.
12. Kim HW, Shim MJ, Choi EC and Kim BK. Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum. Arch Pharm Res 1997;20:425-431.
13. Hattori M, El-Mekkawy S and Meselhy R. Inhibitory effects of components from Ganoderma lucidum on the growth of human immunodeficiency virus (HIV) and the protease activity. In: Proceedings of the 1st International Symposium on Ganoderma Lucidum in Japan, Mizuno T, Ide N and Hasegawa Y (eds), November 17-18, 1997, pp. 128-135.
14. El-Mekkawy S., Meselhy M R., Nakamura N., Tezuka Y., Hattori M., Kakiuchi N., Shimotohno K., Kawahata T., and Otake T. Anti-HIV-1 and anti-HIV-1 protease substances from Ganoderma lucidum. Phytochemistry 49 (1998) 1651-1657
15. Min B.S., Nakamura N., Miyashiro H., Bae K W., and Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull 46 (1998) 1607-1612
16. Triratana S, Thaithatgoon S and Gawgla M. Cultivation of Ganoderma lucidum in sawdust bags. In: Science and Cultivation of Edible Fungi, Maher MJ (ed), Proceedings of the 13th International Congress on the Science Cultivation of Edible Fungi, Dublin, September 1-6, 1991, Rotterdam, A. A. Balkema, pp. 567-572.
17. Kohlmünzer S., Wegiel J., and Sitarz J. Polysaccharides in mycelial culture of Ganoderma applanatum (Pers.) Pat. Herba Hung 28 (1989) 87-94
18. Lin SQ, Wang SZ, Lin SG and Lin ZB. Studies on Ganoderma submerged fermentation and its product extraction technique. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 93-97.
19. Habijanic J., and Berovic M. The relevance of solid-state substrate moisturing on Ganoderma lucidum biomass cultivation. Food Technol Biotechnol 38 (2000) 225-228
20. Berovic M., Habijanic J., Zore I., Wraber B., Hodzar D., Boh B., and Pohleven F. Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides. J Biotechnol 103 (2003) 77-86
21. Mizuno T., Wang G., Zhang J., Kawagishi H., Nishitoba T., and Li J. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substance and medicinal effects. Food Rev Int 11 (1995) 151-166
22. Miyahara R., Yoshimoto T., and Asawa K. Chemical structures and changes of extracts during growth of reishi (Ganoderma lucidum). Mokuzai Gakkaishi 33 (1987) 416-422
23. Chan K. Linking chemical and biological characteristics in assuring the quality of Chinese medicinal materials and OTC products. In: L Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 24-34.
24. Lee JH. Cultivation of reishi (Ganoerma lucidum) [online]. MushWorld - Cultivation, 2000-12-24, available at http://www.mushworld.com/sub_en.html
25. Chen AW. A fresh look at an ancient mushroom Ganoderma lucidum (Reishi) [online]. MushWorld - Cultivation, 2003-03-18, available at http://www.mushworld.com/sub_en.html
26. Chen AW. Natural-log cultivation of the medicinal mushroom Ganoderma lucidum (Reishi) [online]. MushWorld - Cultivation, 2004-01-09, available at http://www.mushworld.com/sub_en.html
27. Sukarno N. Development of Ganoderma lucidum on soft and hard wood logs and determination of organic germanium and ganoderic acid content of the fruiting body produced [online]. MushWorld - Cultivation, 2004-10-06, available at http://www.mushworld.com/sub_en.html
28. Chen AW. Cultivation of the medicinal mushroom Ganoderma lucidum (Curt.: Fr.) P. Karst (Reishi) in North America (3) [online]. MushWorld - Cultivation, 2002-02-01, available at http://www.mushworld.com/sub_en.html
29. Royse D.J. Specialty mushrooms. In: Janick J. (Ed). Progress in New Crops (1996), ASHS Press, Arlington, VA 464-475
30. Chen AW. Growing Ganoderma mushrooms. In: Mushroom Grower's Handbook I, Part III: Mushrooms Worldwide, Chapter 11: Mushrooms for the tropics. ISSN 1739-1377, [online]. MushWorld, 2004, pp. 224-234, available at http://www.mushworld.com/service/handbook/english/eng-book1/chapter11-01_p.224.pdf
31. Yukinori S, Tetsuji S and Yasushi S. Cultivation of Ganoderma lucidum Karst. Patent JP11146728, JMC KK, 1999-06-02.
32. Furci George-Nascimento GM. Ganoderma lucidum (Curt.:Fr.) P. Karst grown indoors on native Chilean hardwoods [online]. MushWorld - Cultivation, 2005-07-30, available at http://www.mushworld.com/sub_en.html
33. Gonzalez-Matute R., Figlas D., Devalis R., Delmastro S., and Curvetto N. Sunflower seed hulls as a main nutrient source for cultivating Ganoderma lucidum. Micologia Aplicada Int. 14 (2002) 19-24
34. Yang F.C., Hsieh C., and Chen H.M. Use of stillage grain from a rice-spirit distillery in the solid state fermentation of Ganoderma lucidum. Process Biochem 39 (2003) 21-26
35. Hsieh C., and Yang F.C. Reusing soy residue for the solid-state fermentation of Ganoderma lucidum. Bioresour Technol 91 (2004) 105-109
36. Kim HK. Comparison of characteristics of Ganoderma lucidum according to geographical origins: consideration of growth characteristics (1) [online]. MushWorld - World Mushroom, 2001-09-01, available at http://www.mushworld.com/sub_en.html
37. Takashi M. Apparatus for cultivating Ganoderma lucidum Karst and other mushrooms and their cultivation. Patent JP11155366, 1999.
38. Kiyoshi K, Hamajirou S and Yoshiaki A. Cultivation method for Ganoderma lucidum (fr.) Karst. Patent JP10084772, 1998.
39. Shigeru Y. Cultivation of Reishi. Patent JP3083521, 1991.
40. Habjanic J and Berovic M. Process of cultivation of fungus Ganoderma lucidum on a solid cultivation substrate. Patent SI 20923, 2002.
41. Li PJ and Shen CG. Method for propagating fungi using solid state fermentation. Patent WO0220727, 2002.
42. Chang M.Y., Tsai G.J., and Houng J.Y. Optimization of the medium composition for the submerged culture of Ganoderma lucidum by Taguchi array design and steepest ascent method. Enzyme Microb Technol 38 (2006) 407-414
43. Hsieh C., Tseng M.H., and Liu C.J. Production of polysaccharides from Ganoderma lucidum (CCRC 36041) under limitations of nutrients. Enzyme Microb Technol 38 (2006) 109-117
44. Zore I, Berovic M, Boh B, Hodzar D and Pohleven F. Procedure for preparation of inoculum for growing of fungus Ganoderma lucidum by submersion fermentation. Patent SI 9700014, 1998.
45. Yang F.C., and Liau C.B. The influence of environmental conditions on polysaccharide formation by Ganoderma lucidum in submerged cultures. Process Biochem 33 (1998) 547-553
46. Lee K.M., Lee S.Y., and Lee H.Y. Bistage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor. J Biosci Bioeng 88 (1999) 646-650
47. Fang Q.H., and Zhong J.J. Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of Ganoderma lucidum. Process Biochem 37 (2002) 769-774
48. Fang Q.H., and Zhong J.J. Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites - ganoderic acid and polysaccharide. Biochem Eng J 10 (2002) 61-65
49. Fang Q.H., Tang Y.j., and Zhong J.J. Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochem 37 (2002) 1375-1379
50. Tang Y.J., and Zhong J.J. Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acid. Enzyme Microb Tech 31 (2002) 20-28
51. Tang Y.J., and Zhong J.J. Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid. Enzyme Microb Technol 32 (2003) 478-484
52. Hsieh C., Hsu T.H., and Yang F.C. Production of polysaccharides of Ganoderma lucidum (CCRC36021) by reusing thin stillage. Process Biochem 40 (2005) 909-916
53. Lee H., Song M., Yu Y., and Hwang S. Production of Ganoderma lucidum mycelium using cheese whey as an alternative substrate: response surface analysis and biokinetics. Biochem Eng J 15 (2003) 93-99
54. Lee H., Song M., Yu Y., and Hwang S. Optimizing bioconversion of deproteinated cheese whey to mycelia of Ganoderma lucidum. Process Biochem 38 (2003) 1685-1693
55. Hirotani M., Ino C., Furuya T., and Shiro M. Ganoderic acids T, S, and R, new triterpenoids from the cultured media of Ganoderma lucidum. Chem Pharm Bull 34 (1986) 2282-2285
56. Kikuchi T., Kanomi S., Murai Y., Kadota S., Tsubono K., and Ogita Z. Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I. Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds. Chem Pharm Bull 34 (1986) 3695-3712
57. Morigiwa A., Kitabatake K., Fujimoto Y., and Ikekawa N. Angiotensin converting enzyme inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull 34 (1986) 3025-3028
58. Nishitoba T., Sato H., and Sakamura S. Triterpenoids from the fungus Ganoderma lucidum. Phytochemistry 26 (1987) 1777-1784
59. Nishitoba T., Goto S., Sato H., and Sakamura S. Bitter triterpenoids from the fungus Ganoderma applanatum. Phytochemistry 28 (1989) 193-197
60. Lin L.J., and Shiao M.S. Seven new triterpenes from Ganoderma lucidum. J Nat Prod 51 (1988) 918-924
61. Lin L.J., Shiao M.S., and Yeh S.F. Triterpenes from Ganoderma lucidum. Phytochem 27 (1988) 2269-2271
62. Shiao M.S., Lin L.J., Yeh S.F., and Chou C.S. Two new triterpenes of the fungus Ganoderma lucidum. J Nat Prod 50 (1987) 886-890
63. Chairul, Tokuyama T., Hayashi Y., Nishizawa M., Tokuda H., Chairul S.M., and Hayashi Y. Applanoxidic acids A, B, C and D, biologically active tetracyclic triterpenes from Ganoderma applanatum. Phytochem 30 (1991) 4105-4109
64. Chairul, Hayashi Y., and Chairul S.M. Lanostanoid triterpenes from Ganoderma applanatum. Phytochem 35 (1994) 1305-1308
65. Boh B., Hodzar D., Dolnicar D., Berovic M., and Pohleven F. Isolation and quantification of triterpenoid acids from Ganoderma applanatum of Istrian origin. Food Technol Biotechnol 1 (2000) 11-18
66. Kim D.H., Shim S.B., Kim N.J., and Jang I.S. Beta-glucuronidase-inhibitory and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 22 (1999) 162-164
67. Toth J.O., Luu B., and Ourisson G. Les acides ganoderiques T a Z: triterpenes cytotoxiques de Ganoderma lucidum (Polyporaceae). Tetrahedron Lett 24 (1983) 1081-1084
68. Lin SB, Li CH, Chen YR, Kan LS and Lee SS. Triterpene extract from Ganoderma lucidum inhibits growth of hepatoma Huh7 cells: involvement of oxidative stress induction. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 176-182.
69. Gao J.J., Min B.S., Ahn E.M., Nakamura N., Lee H.K., and Hattori M. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull (Tokyo) 50 (2002) 837-840
70. Min B.S., Gao J.J., Nakamura N., and Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull (Tokyo) 48 (2000) 1026-1033
71. Lin S.B., Li C.H., Lee S.S., and Kan L.S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72 (2003) 2381-2390
72. Zhu H.S., Yang X.L., Wang L.B., Zhao D.X., and Chen L. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 16 (2000) 201-206
73. Yu S.P., Zhang J.S., Tang Q.J., Shi X.M., Liu Y.F., Yan Y., and Pan Y.L. Correlation between intracellular triterpenes from mycelia of Ganoderma lucidum in different growth stages and inhibition effect on tumor cells. Mycosystema 23 (2004) 548-554
74. Liu J., Shimizu K., Konishi F., Noda K., Kumamoto S., Kurashiki K., and Kondo R. Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum. Food Chem 100 (2007) 1691-1696
75. Mueller C.I., Kumagai T., Kelly J.O., Seeram N.P., Heber D., and Koeffler H.P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leukemia Res 30 (2006) 841-848
76. Kimura Y., Taniguchi M., and Baba K. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22 6A (2002) 3309-3318
77. Kabir Y., Kimura S., and Tamura T. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hipertensive rats. J Nat Sci Vitaminol 34 (1988) 433-438
78. Kohda H., Tokumoto W., Sakamoto K., Fujii M., Hirai Y., Yamasaki K., Komoda Y., Nakamura H., Ishihara S., and Uchida M. The biologically active constituents of Ganoderma lucidum (Fr.) Karst histamine release-inhibitory triterpenes. Chem Pharm Bull 33 (1985) 1367-1374
79. Wang C.N., Chen J.C., Shiao M.S., and Wang C.T. The aggregation of human platelet induced by ganodermic acid S. Biochim Biophys Acta 986 (1989) 151-160
80. Wang C.N., Chen J.C., Shiao M.S., and Wang C.T. The inhibition of human platelet function by ganodermic acids. Biochem J 277 (1991) 189-197
81. Su C.Y., Shiao M.S., and Wang C.T. Predominant inhibition of ganodermic acid S on the thromboxane A2 -dependent pathway in human platelets response to collagen. Biochim Biophys Acta 1437 (1999) 223-234
82. Su C., Shiao M., and Wang C. Potentiation of ganoderemic acid S on prostaglandin E(1)-induced cyclic AMP elevation in human platelets. Thromb Res 99 (2000) 135-145
83. Min B.S., Gao J.J., Hattori M., Lee H.K., and Kim Y.H. Anticomplement activity of triterpenoids from the spores of Ganoderma lucidum. Planta Med 67 (2001) 811-814
84. Fang JN, Bao XF and Yuen WH. Studies on the polysaccharides from spores of Ganoderma lucidum. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 98-103.
85. Lin SQ, Wang SZ, Lin ZB and Lin YX. Purification and identification of glycopeptides from Ganoderma lucidum fruit bodies cultivated with grass and wood log. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 109-114.
86. Zhang Q.H., and Lin Z.B. Effect of Ganoderma lucidum polysaccharides B on TNF-α and INF-γ production and their mRNA expression. J Beijing Med Univ 31 (1999) 179-183
87. Russell R., and Paterson M. Ganoderma - A therapeutic fungal biofactory. Phytochem 67 (2006) 1985-2001
88. Sasaki T., Arai Y., Ikekawa T., Chihara G., and Fukuoka F. Antitumor polysaccharides from some Polyporaceae, Ganoderma applanatum (Pers.) Pat. and Phellinus linteus (Berk. Et Curt) Aoshima. Chem Pharm Bull 19 (1971) 821-826
89. Lee S.S., Chen F.D., Chang S.C., Wei Y.H., Liu I., and Chen C. In vivo antitumor effect of crude extracts from the mycelium of Ganoderma lucidum. Bull Chinese Oncol Soc 5 (1984) 22-27
90. Hwang S.F., Liu K.J., Kuan Y.H., Tung K.S., Su C.H., and Tung T.C. The inhibitory effect on artificial pulmonary metastasis of murine S-180 Sarcoma cells by orally administered Ganoderma lucidum. J Chim Oncol Soc 5 (1989) 10-15
91. Furusawa E., Chou S.C., Furasawa S., Hirazum A., and Dang Y. Antitumor activity of Ganoderma lucidum, and edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergeneic mice. Phytother Res 6 (1992) 300-304
92. Zhang Q., and Lin Z.B. The antitumor activity of Ganoderma lucidum (Curt,:Fr.) P. Karst. (Lingzhi) (Aphylophoromycetidae) polysaccharides is related to tumor necrosis factor-α and interferon-γ. Int J Med Mushroom 1 (1999) 207-215
93. Lu H., Kyo E., Uesaka T., Katoh O., and Watanabe H. Prevention of development of N,N′-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med 9 (2002) 113-117
94. Liu X., Yuan J.P., Chuang C.K., and Chen X.J. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett 182 (2002) 155-161
95. Lu H., Kyo E., Uesaka T., Katoh O., and Watanabe H. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep 10 (2003) 375-379
96. Hu Y.H., and Lin Z.B. Polysaccharides isolated from mycelia of Ganoderma lucidum induced HL-60 cell apoptosis by enhancing macrophage activity. Chin Pharmacol Bull 5 (1999) 27-30
97. Hu Y.H., and Lin Z.B. Effects of polysaccharides isolated from mycelia of Ganoderma lucidum on HL-60 cell apoptosis. Acta Pharm Sin 34 (1999) 268-271
98. Zhang N.Q. Basic Theory of Traditional Chinese Medicine, 1st edn Vol. I (1990), People Sanitation Press, Beijing pp. 199-205
99. Lin Z.B. Modern Research of Ganoderma lucidum. 2nd edn (2001), Beijing Medical University Press, Beijing (Chapter 1 and 8)
100. Lei LS, Li MC and Sun LS. Ganoderma lucidum and its components on the function of macrophages. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 20-23.
101. Shiuh S., Yau H., Chieh F., Sheng Y., and Kuang Y. Antitumor effects of Ganoderma lucidum. J Chin Med 6 (1995) 1-12
102. Wang S.Y., Hsu M.L., Hsu H.C., Tzeng C.H., Lee S.S., Shiao M.S., and Ho C.K. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocyes. Int J Cancer 70 (1997) 699-705
103. Zhang Q.H., and Lin Z.B. The antitumor activity of Ganoderma lucidum (Curt; Fr.) P. Karst (Ling Zhi) (Aphyllophoromycetideae) polysaccharides is related to tumor necrosis factor-α and interferon-γ. Int J Med Mushroom 1 (1999) 207-215
104. Boh B., Berovic M., Wraber B., Hodzar D., Habijanic J., Pohleven F., and Zore I. Ganoderma lucidum (W.Curt.:Fr.) Lloyd and G. applanatum (Pers.) Pat. (Aphyllophoromycetideae) from Slovenian habitats: cultivation, isolation, and testing of active compounds. Int J Medic Mushroom 6 (2004) 15-32
105. Lee SS, Lee PL, Chen CF, Wang SY and Chen KY. Antitumor effects of Ganoderma lucidum. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 46-57.
106. Cao LZ and Lin ZB. Regulation of Ganoderma lucidum polysaccharides on cytotoxic T lymphocytes induced by dendric cells in vitro. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 122-129.
107. Lei L., Lin Z., Chen Q., Li R., and He Y. Antagonistic effect of Ganoderma lucidum polysaccharide on the immunosuppressive response induced by cyclosporin A, hydrocortisone and antitumor agents. Chin J Pharmacol Toxicol 7 (1993) 183-185
108. Li M., Lei L., and Liang D. Effect of Ganoderma polysaccharide on intracellular free calcium in murine peritoneal macrophages. Chin Pharm J 34 (1999) 805-807
109. Cao L.Z., and Lin Z.B. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett 83 (2002) 163-169
110. Cao L.Z., and Lin Z.B. Regulation effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol Sin 24 (2003) 321-326
111. Shao B.M., Dai H., Xu W., Lin Z.B., and Gao X.M. Immune receptors for polysaccharides form Ganoderma lucidum. Biochem Bioph Res Commun 323 (2004) 133-141
112. Chien C.M., Cheng J.L., Chang W.T., Tien M.H., Tsao C.M., Chang Y.H., Chang H.Y., Hsieh J.F., Wong C.H., and Chen S.T. Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood. Bioorg Med Chem 12 (2004) 5603-5609
113. Lei L.S., and Lin Z.B. Effects of Ganoderma polysaccharides on the activity of DNA polymerase in spleen cells stimulated by alloantigents in mice in vitro. J Beijing Med Univ 23 (1991) 329-333
114. Lei L.S., and Lin Z.B. Effects of Ganoderma polysaccharides on the MLC reaction. Basic Med Clin 12 (1992) 59-60
115. Cao L.Z., and Lin Z.B. Comparison of the effects of polysaccharides from wood-cultured and bag-cultured Ganoderma lucidum on murine spleen lymphocyte proliferation in vitro. Acta Pharmacol Sin 38 (2003) 92-97
116. Bao X.F., Wang X.S., Dong Q., Fang J.N., and Li X.Y. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochem 59 (2002) 175-181
117. Zhang J.S., Tang Q.J., Zimmerman-Kordmann M., Reuter W., and Fan H. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci 71 (2002) 623-638
118. Liu Y.H., Tsai C.F., Kao M.C., Lai Y.L., and Tsai J.J. Effectiveness of Dp2 nasal therapy for Dp2-induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator. J Microbiol Immunol Infect 36 (2003) 236-242
119. Lin Z.B., and Wang P.Y. The Pharmacological Study of Ganoderma Spores and Its Active Components. J Peking Univ (Health Sciences) 38 5 (2006) 541-547
120. Xu X., Hou G.H., Cao R.H., and Xie W.G. Study on mechanism of Ganodermaa lucidum polysaccharides enhancing activity of LAK cells from human cord blood. Chinese J Cancer Biotherapy 4 (1997) 236
121. Lin ZB and Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 2004;25:1387-1391.
122. Lu P.H., and Negrin R.S. A novel population of expended human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153 (1994) 1687-1696
123. Zhu X.L., and Lin Z.B. Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharm Sin 26 (2005) 1130-1137
124. Zhu X.L., and Lin Z.B. Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohyd Polym 63 (2006) 188-197
125. Wang Y.Y., Khoo K.H., Chen S.T., Lin C.C., Wong C.H., and Lin C.H. Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and protewmic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorg Med Chem 10 (2002) 1057-1062
126. Chen H.S., Tsai Y.F., Lin S., Lin C.C., Khoo K.H., Lin C.H., and Wong C.H. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem 12 (2004) 5595-5601
127. Yuen M.F., Ip P., Ng W.K., and Lai C.L. Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi). Letters to the editor. J Hepatol 41 (2004) 685-690
128. Wang X.X., Tang Q.J., Zhang J.S., Yang Y., Liu Y.F., Jia W., and Liu F. Effect of various grades of Ganoderma lucidum on tumor inhibition and immunostimulation. Acta Edul Fung 12 (2005) 48-51
129. Zhang J.S., Jia W., Xing Z.T., Tang Q.J., Liu Y.F., Yang Y., Zhou C.Y., and Liu F. Comparison of bioactivity of fruiting body and mycelia of Ganoderma lucidum and their purified fractions. Mycosystema 23 (2004) 85-92
130. Cao Q.Z., and Lin Z.B. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 25 (2004) 833-838
131. Cao Q.Z., and Lin Z.B. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 78 (2006) 1457-1463
132. Song Y.S., Kim S.H., Sa J.H., Jin C., Lim C.L., and Park E.H. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 90 (2004) 17-20
133. Stanley G., Harvey K., Slivova V., Jiang J., and Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells. Biochem Biophys Res Com 330 (2005) 46-52
134. You YH and Lin ZB. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin 2002;23:878-891.
135. 2-induced oxidative damage to cellular DNA. Teratogen Carcin Mut 22 (2002) 103-111
136. Zhang H.N., He J.H., Yuan L., and Lin Z.B. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci 73 (2003) 2307-2319
137. Lakshmi B., Ajith T.A., Jose N., and Janardhanan K.K. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol 107 (2006) 297-303
138. Van der Hem L.G., van der Vliet J.A., Bocken C.F., Kino K., Hoitsma H.J., and Tax W.J. Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 60 (1995) 438-443
139. Tian Y.P., and Zhang K.C. Purification and characterization of a novel proteinase A inhibitor from Ganoderma lucidum by submerged fermentation. Enzyme Microb Technol 36 (2005) 357-361
140. Liu J., Yang F., Ye L.B., Yang X.J., Timani K.A., Zheng Y., and Wang Y.H. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Ethnopharmacol 95 (2004) 256-272
141. Wang H.X., Ng T.B., and Chiu S.W. A distinctive ribonuclease from fresh fruiting bodies of the medicinal mushroom Ganoderma lucidum. Biochem Biophys Res Com 314 (2004) 519-522
142. Wang H.X., and Ng T.B. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides 27 (2006) 27-30
143. Chang S.T., and Buswell J.A. Mushroom nutriceuticals. World J Microbiol Biotechnol 12 (1996) 473-476
144. Wasser S.P., and Weiss A.L. Medicinal Mushrooms - Ganoderma lucidum, Reishi Mushroom (1997), Pedeifus Publishing House, Haifa
145. Zhang CY and Li YM. Clinical investigation of Green Valley Lingzhi capsule on type 2 diabetes mellitus. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 194-198.
146. Shi KG and Quing LH. The follow-up observation assessment of medium and late phases cancer treated by Chinese Ganoderma lucidum essence (CGLE). In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics, Zhi-Bin Lin (ed), Proceedings of International Symposium on Ganoderma Research, Shanghai, October 21-23, 2002, Beijing, Medical University Press, pp. 188-193.
147. Sliva D., Labarrere C., Slivova S., Sedlak M., Lloyd F.P., and Ho N.W. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298 (2002) 603-612
148. Noguchi M., Kakuma T., Tomiyasu K., Konishi F., Kumamoto S., Kondo R., and Matsuoka K. Phase I study of a methanol extract of Ganoderma lucidum, edible and medicinal mushroom, in men with mild symptoms of bladder outlet obstruction. Urology 66 suppl. 3A (2005) 21
149. Chen X., Hu Z.P., Yang X.X., Huang M., Gao Y., Tang W., Chan S.Y., Dai X., Ye J., Ho P.C., Duan W., Yang H.Y., Zhu Y.Z., and Zhou S.F. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. Int Immunopharmacol 6 (2006) 499-508
150. Ghafa M.A., Golliday E., Bingham J., Mansukhani M.M., Anastasiasis A.G., and Katz A.E. Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report. J Altern Complement Med 8 (2002) 493-497
151. Gao Y., Zhou S., Jiang W., Huang M., and Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32 (2003) 201-215
152. Gao Y, Tang W, Dai X, Chen G, Ye J, Chen E, Koh HL, Li X, and Zhou S, Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food 2005;8:159-168.
153. Chan W.K., Lam D.T., Law H.K., Wong W.T., Leung K.M.W., Lau Y.L., and Chan G.C. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med 11 (2005) 1047-1057